We are live on ! Find out more
Dimensional Fund Advisors

Dimensional Fund Advisors Portfolio holdings

AUM $551B Turnover 5.23%
1-Year Est. Return 33.95%
 

Dimensional Fund Advisors runs its own versions of index funds, which lean toward smaller company and value stocks. Its approach is to take a long-term view and focus systematically on the sources of expected returns, rather than picking stocks or timing the market. Its founders, David Booth, Rex Sinquefield and Larry Klotz, started it in 1981 after studying at the University of Chicago. The firm is privately owned, and David Booth, one of its founders, is its executive chairman and a principal owner. For decades Dimensional sold only to institutions and through registered advisers, before offering ETFs to the general public in 2020.

This Fund
S&P 500
This Quarter Est. Return
+2.06%
1 Year Est. Return
+33.95%
3 Year Est. Return
+121.78%
5 Year Est. Return
+156.88%
10 Year Est. Return
+543.62%
AUM
$551B
AUM Growth
-$1.03B
Cap. Flow
+$5.13B
Cap. Flow %
0.93%
Top 10 Hldgs %
19.21%
Holding
3,309
New
88
Increased
2,018
Reduced
1,018
Closed
85
Avg Time Held
9.1 years
Top 10 Avg Time Held
5.3 years
Top 20 Avg Time Held
4.9 years

Sector Composition

Rank Sector Weight
1 Technology 24.94%
2 Financials 16.92%
3 Industrials 11.57%
4 Healthcare 10.09%
5 Consumer Discretionary 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
OPRX icon
2576
OptimizeRx
OPRX
$127M
$3.7M ﹤0.01%
443,016
-34,671
-7% -$250K
2020 Q4
23 quarters
PINE icon
2577
Alpine Income Property Trust
PINE
$292M
$3.67M ﹤0.01%
211,353
+13,445
+7% +$262K
2021 Q4
19 quarters
EYPT icon
2578
EyePoint
EYPT
$26.6M
$3.63M ﹤0.01%
1,110,222
+268,476
+32% +$2.36M
2021 Q2
21 quarters
ATHM icon
2579
Autohome
ATHM
$2.34B
$3.63M ﹤0.01%
170,780
-163,281
-49% -$3.54M
2025 Q2
5 quarters
REPL icon
2580
Replimune Group
REPL
$1.81B
$3.61M ﹤0.01%
272,636
-229,494
-46% -$2.9M
2020 Q2
25 quarters
LRMR icon
2581
Larimar Therapeutics
LRMR
$329M
$3.61M ﹤0.01%
1,129,697
+168,614
+18% +$652K
2021 Q3
20 quarters
SABR icon
2582
Sabre
SABR
$662M
$3.59M ﹤0.01%
1,695,019
+720,397
+74% +$1.48M
2023 Q3
12 quarters
CZFS icon
2583
Citizens Financial Services
CZFS
$388M
$3.57M ﹤0.01%
45,450
+13,811
+44% +$1.09M
2024 Q1
10 quarters
VRA icon
2584
Vera Bradley
VRA
$142M
$3.57M ﹤0.01%
771,887
-39,068
-5% -$141K
2013 Q2
53 quarters
FXNC icon
2585
First National
FXNC
$258M
$3.56M ﹤0.01%
121,223
+18,785
+18% +$575K
2023 Q4
11 quarters
BIOA icon
2586
BioAge Labs
BIOA
$197M
$3.54M ﹤0.01%
499,916
+105,778
+27% +$1.47M
2026 Q1
2 quarters
RCKT icon
2587
Rocket Pharmaceuticals
RCKT
$218M
$3.54M ﹤0.01%
1,346,107
+220,607
+20% +$765K
2018 Q4
31 quarters
XENE icon
2588
Xenon Pharmaceuticals
XENE
$3.64B
$3.51M ﹤0.01%
94,419
+57,824
+158% +$3.44M
2026 Q2
1 quarter
FRAF icon
2589
Franklin Financial Services
FRAF
$300M
$3.51M ﹤0.01%
56,799
+7,401
+15% +$465K
2019 Q4
27 quarters
SGHT icon
2590
Sight Sciences
SGHT
$566M
$3.47M ﹤0.01%
370,755
-12,757
-3% -$90.7K
2023 Q1
14 quarters
MRP icon
2591
Millrose Properties
MRP
$4.06B
$3.44M ﹤0.01%
132,473
+35,817
+37% +$1.04M
2025 Q1
6 quarters
PHR icon
2592
Phreesia
PHR
$708M
$3.44M ﹤0.01%
333,125
+11,995
+4% +$132K
2022 Q1
18 quarters
NPB icon
2593
Northpointe Bancshares
NPB
$501M
$3.44M ﹤0.01%
235,882
+160,458
+213% +$2.77M
2026 Q2
1 quarter
AXSM icon
2594
Axsome Therapeutics
AXSM
$6.8B
$3.43M ﹤0.01%
18,595
-4,075
-18% -$886K
2025 Q1
6 quarters
FMC icon
2595
FMC
FMC
$605M
$3.42M ﹤0.01%
383,157
-268,605
-41% -$2.94M
2013 Q2
53 quarters
EMA icon
2596
Emera
EMA
$16B
$3.39M ﹤0.01%
70,798
+45,057
+175% +$2.32M
2025 Q4
3 quarters
MYGN icon
2597
Myriad Genetics
MYGN
$524M
$3.38M ﹤0.01%
784,445
-267,551
-25% -$1.13M
2013 Q2
53 quarters
CATX icon
2598
Perspective Therapeutics
CATX
$91M
$3.37M ﹤0.01%
1,227,846
+153,775
+14% +$466K
2025 Q4
3 quarters
FLWS icon
2599
1-800-Flowers.com
FLWS
$120M
$3.36M ﹤0.01%
1,345,239
-78,604
-6% -$286K
2013 Q2
53 quarters
ORGO icon
2600
Organogenesis Holdings
ORGO
$100M
$3.36M ﹤0.01%
2,449,003
-601,294
-20% -$1.18M
2021 Q3
20 quarters

Similar funds

Dimensional Fund Advisors's Q3 2026 Portfolio in Review

As of Q3 2026, Dimensional Fund Advisors held 3,309 positions worth $551B, down 0.19% from $552B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Dimensional Fund Advisors's Q3 2026 filing shows 88 new, 2,018 increased, 1,018 reduced and 85 closed positions. Its largest new stake was Liberty Media Series C: 2,033,116 shares worth $188M. The largest sale was Taylor Morrison, an estimated $467M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Industrials.

  • Dimensional Fund Advisors's largest Q3 2026 buy was Liberty Media Series C: 2,033,116 shares worth $188M.
  • Dimensional Fund Advisors added most to Amazon in Q3 2026, an estimated $710M increase.
  • Dimensional Fund Advisors's biggest Q3 2026 reduction was Cisco, cutting an estimated $458M.
  • Dimensional Fund Advisors fully exited Taylor Morrison in Q3 2026, selling an estimated $467M.
  • Dimensional Fund Advisors's ten largest holdings make up 19% of its $551B portfolio in Q3 2026.
  • Dimensional Fund Advisors opened 88 new positions and closed 85 in Q3 2026.
  • Dimensional Fund Advisors's portfolio value fell 0.19% quarter-over-quarter to $551B.

Based on Dimensional Fund Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.